Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

AVAH vs MMS vs TDOC vs CACI vs SAIC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AVAH
Aveanna Healthcare Holdings Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.42B
5Y Perf.-42.3%
MMS
Maximus, Inc.

Specialty Business Services

IndustrialsNYSE • US
Market Cap$3.51B
5Y Perf.-29.9%
TDOC
Teladoc Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$1.31B
5Y Perf.-95.8%
CACI
CACI International Inc

Information Technology Services

TechnologyNYSE • US
Market Cap$10.62B
5Y Perf.+88.7%
SAIC
Science Applications International Corporation

Information Technology Services

TechnologyNASDAQ • US
Market Cap$4.23B
5Y Perf.+5.0%

AVAH vs MMS vs TDOC vs CACI vs SAIC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AVAH logoAVAH
MMS logoMMS
TDOC logoTDOC
CACI logoCACI
SAIC logoSAIC
IndustryMedical - Care FacilitiesSpecialty Business ServicesMedical - Healthcare Information ServicesInformation Technology ServicesInformation Technology Services
Market Cap$1.42B$3.51B$1.31B$10.62B$4.23B
Revenue (TTM)$2.43B$5.32B$2.51B$9.16B$7.26B
Net Income (TTM)$225M$373M$-171M$537M$358M
Gross Margin33.1%24.6%65.6%14.9%12.0%
Operating Margin10.9%10.8%-7.6%9.3%7.1%
Forward P/E11.6x7.7x17.1x9.3x
Total Debt$1.34B$1.44B$1.04B$3.34B$217M
Cash & Equiv.$193M$260M$781M$106M$182M

AVAH vs MMS vs TDOC vs CACI vs SAICLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AVAH
MMS
TDOC
CACI
SAIC
StockApr 21May 26Return
Aveanna Healthcare … (AVAH)10057.7-42.3%
Maximus, Inc. (MMS)10070.1-29.9%
Teladoc Health, Inc. (TDOC)1004.2-95.8%
CACI International … (CACI)100188.7+88.7%
Science Application… (SAIC)100105.0+5.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: AVAH vs MMS vs TDOC vs CACI vs SAIC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AVAH leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Maximus, Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. SAIC also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
AVAH
Aveanna Healthcare Holdings Inc.
The Growth Play

AVAH carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 20.2%, EPS growth 19.5%, 3Y rev CAGR 10.8%
  • 20.2% revenue growth vs SAIC's -2.9%
  • 9.2% margin vs TDOC's -6.8%
  • +22.5% vs SAIC's -21.7%
Best for: growth exposure
MMS
Maximus, Inc.
The Income Pick

MMS is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.

  • Dividend streak 2 yrs, beta 0.63, yield 1.8%
  • Beta 0.63, yield 1.8%, current ratio 1.64x
  • Lower P/E (7.7x vs 17.1x), PEG 0.76 vs 1.41
  • 1.8% yield, 2-year raise streak, vs SAIC's 1.6%, (3 stocks pay no dividend)
Best for: income & stability and defensive
TDOC
Teladoc Health, Inc.
The Healthcare Pick

TDOC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
CACI
CACI International Inc
The Long-Run Compounder

CACI is the clearest fit if your priority is long-term compounding.

  • 406.9% 10Y total return vs SAIC's 104.0%
Best for: long-term compounding
SAIC
Science Applications International Corporation
The Defensive Pick

SAIC ranks third and is worth considering specifically for sleep-well-at-night and valuation efficiency.

  • Lower volatility, beta 0.27, Low D/E 14.5%, current ratio 1.20x
  • PEG 0.56 vs CACI's 1.41
  • Beta 0.27 vs TDOC's 1.89, lower leverage
Best for: sleep-well-at-night and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthAVAH logoAVAH20.2% revenue growth vs SAIC's -2.9%
ValueMMS logoMMSLower P/E (7.7x vs 17.1x), PEG 0.76 vs 1.41
Quality / MarginsAVAH logoAVAH9.2% margin vs TDOC's -6.8%
Stability / SafetySAIC logoSAICBeta 0.27 vs TDOC's 1.89, lower leverage
DividendsMMS logoMMS1.8% yield, 2-year raise streak, vs SAIC's 1.6%, (3 stocks pay no dividend)
Momentum (1Y)AVAH logoAVAH+22.5% vs SAIC's -21.7%
Efficiency (ROA)AVAH logoAVAH12.4% ROA vs TDOC's -5.9%, ROIC 15.1% vs -11.5%

AVAH vs MMS vs TDOC vs CACI vs SAIC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AVAHAveanna Healthcare Holdings Inc.
FY 2025
Private Duty Services
82.2%$2.0B
Home Health And Hospice
10.2%$249M
Medical Solutions
7.5%$183M
MMSMaximus, Inc.
FY 2025
Clinical Services
86.6%$2.1B
Advanced Technology Solutions
13.4%$325M
TDOCTeladoc Health, Inc.
FY 2025
Other
100.0%$438M
CACICACI International Inc
FY 2025
Technology Service
55.4%$4.8B
Service, Other
44.6%$3.8B
SAICScience Applications International Corporation
FY 2025
Defense And Intelligence
100.0%$5.7B

AVAH vs MMS vs TDOC vs CACI vs SAIC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAVAHLAGGINGCACI

Income & Cash Flow (Last 12 Months)

AVAH leads this category, winning 4 of 6 comparable metrics.

CACI is the larger business by revenue, generating $9.2B annually — 3.8x AVAH's $2.4B. AVAH is the more profitable business, keeping 9.2% of every revenue dollar as net income compared to TDOC's -6.8%. On growth, AVAH holds the edge at +27.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricAVAH logoAVAHAveanna Healthcar…MMS logoMMSMaximus, Inc.TDOC logoTDOCTeladoc Health, I…CACI logoCACICACI Internationa…SAIC logoSAICScience Applicati…
RevenueTrailing 12 months$2.4B$5.3B$2.5B$9.2B$7.3B
EBITDAEarnings before interest/tax$289M$645M$42M$1.1B$666M
Net IncomeAfter-tax profit$225M$373M-$171M$537M$358M
Free Cash FlowCash after capex$126M$372M$251M$470M$609M
Gross MarginGross profit ÷ Revenue+33.1%+24.6%+65.6%+14.9%+12.0%
Operating MarginEBIT ÷ Revenue+10.9%+10.8%-7.6%+9.3%+7.1%
Net MarginNet income ÷ Revenue+9.2%+7.0%-6.8%+5.9%+4.9%
FCF MarginFCF ÷ Revenue+5.2%+7.0%+10.0%+5.1%+8.4%
Rev. Growth (YoY)Latest quarter vs prior year+27.4%-4.1%-2.5%+8.5%-4.8%
EPS Growth (YoY)Latest quarter vs prior year+4.9%+6.5%+32.1%+17.8%-6.5%
AVAH leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

TDOC leads this category, winning 4 of 7 comparable metrics.

At 6.4x trailing earnings, AVAH trades at a 70% valuation discount to CACI's 21.5x P/E. Adjusting for growth (PEG ratio), SAIC offers better value at 0.73x vs CACI's 1.78x — a lower PEG means you pay less per unit of expected earnings growth.

MetricAVAH logoAVAHAveanna Healthcar…MMS logoMMSMaximus, Inc.TDOC logoTDOCTeladoc Health, I…CACI logoCACICACI Internationa…SAIC logoSAICScience Applicati…
Market CapShares × price$1.4B$3.5B$1.3B$10.6B$4.2B
Enterprise ValueMkt cap + debt − cash$2.6B$4.7B$1.6B$13.9B$4.3B
Trailing P/EPrice ÷ TTM EPS6.42x11.66x-6.36x21.55x12.20x
Forward P/EPrice ÷ next-FY EPS est.11.61x7.72x17.07x9.31x
PEG RatioP/E ÷ EPS growth rate1.14x1.78x0.73x
EV / EBITDAEnterprise value multiple8.90x6.49x15.65x14.44x6.42x
Price / SalesMarket cap ÷ Revenue0.58x0.65x0.52x1.23x0.58x
Price / BookPrice ÷ Book value/share7.45x2.22x0.92x2.77x2.91x
Price / FCFMarket cap ÷ FCF11.30x9.57x4.58x22.07x7.33x
TDOC leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

AVAH leads this category, winning 4 of 9 comparable metrics.

AVAH delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-12 for TDOC. SAIC carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVAH's 6.91x. On the Piotroski fundamental quality scale (0–9), MMS scores 8/9 vs TDOC's 6/9, reflecting strong financial health.

MetricAVAH logoAVAHAveanna Healthcar…MMS logoMMSMaximus, Inc.TDOC logoTDOCTeladoc Health, I…CACI logoCACICACI Internationa…SAIC logoSAICScience Applicati…
ROE (TTM)Return on equity+9.5%+21.8%-12.4%+13.1%+23.7%
ROA (TTM)Return on assets+12.4%+8.8%-5.9%+5.7%+6.8%
ROICReturn on invested capital+15.1%+15.1%-11.5%+9.2%+14.2%
ROCEReturn on capital employed+18.6%+17.4%-10.0%+11.6%+12.5%
Piotroski ScoreFundamental quality 0–968677
Debt / EquityFinancial leverage6.91x0.86x0.75x0.86x0.14x
Net DebtTotal debt minus cash$1.2B$1.2B$259M$3.2B$35M
Cash & Equiv.Liquid assets$193M$260M$781M$106M$182M
Total DebtShort + long-term debt$1.3B$1.4B$1.0B$3.3B$217M
Interest CoverageEBIT ÷ Interest expense1.79x4.93x-8.76x4.52x3.99x
AVAH leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

AVAH leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in CACI five years ago would be worth $18,233 today (with dividends reinvested), compared to $514 for TDOC. Over the past 12 months, AVAH leads with a +22.5% total return vs SAIC's -21.7%. The 3-year compound annual growth rate (CAGR) favors AVAH at 87.7% vs TDOC's -34.7% — a key indicator of consistent wealth creation.

MetricAVAH logoAVAHAveanna Healthcar…MMS logoMMSMaximus, Inc.TDOC logoTDOCTeladoc Health, I…CACI logoCACICACI Internationa…SAIC logoSAICScience Applicati…
YTD ReturnYear-to-date-16.6%-25.3%+2.8%-10.5%-6.5%
1-Year ReturnPast 12 months+22.5%-13.5%+2.4%+1.0%-21.7%
3-Year ReturnCumulative with dividends+560.8%-14.6%-72.2%+58.2%-1.0%
5-Year ReturnCumulative with dividends-41.9%-22.2%-94.9%+82.3%+12.2%
10-Year ReturnCumulative with dividends-43.8%+35.3%-38.7%+406.9%+104.0%
CAGR (3Y)Annualised 3-year return+87.7%-5.1%-34.7%+16.5%-0.3%
AVAH leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

SAIC leads this category, winning 2 of 2 comparable metrics.

SAIC is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than TDOC's 1.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SAIC currently trades 75.7% from its 52-week high vs MMS's 64.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAVAH logoAVAHAveanna Healthcar…MMS logoMMSMaximus, Inc.TDOC logoTDOCTeladoc Health, I…CACI logoCACICACI Internationa…SAIC logoSAICScience Applicati…
Beta (5Y)Sensitivity to S&P 5001.29x0.63x1.89x0.29x0.27x
52-Week HighHighest price in past year$10.32$100.00$9.77$683.50$124.11
52-Week LowLowest price in past year$3.73$60.75$4.40$409.62$81.08
% of 52W HighCurrent price vs 52-week peak+65.3%+64.3%+74.2%+70.4%+75.7%
RSI (14)Momentum oscillator 0–10057.949.776.133.745.7
Avg Volume (50D)Average daily shares traded1.1M685K5.2M270K556K
SAIC leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

MMS leads this category, winning 1 of 1 comparable metric.

Analyst consensus: AVAH as "Hold", MMS as "Buy", TDOC as "Hold", CACI as "Buy", SAIC as "Hold". Consensus price targets imply 71.2% upside for MMS (target: $110) vs 3.8% for SAIC (target: $98). For income investors, MMS offers the higher dividend yield at 1.85% vs SAIC's 1.60%.

MetricAVAH logoAVAHAveanna Healthcar…MMS logoMMSMaximus, Inc.TDOC logoTDOCTeladoc Health, I…CACI logoCACICACI Internationa…SAIC logoSAICScience Applicati…
Analyst RatingConsensus buy/hold/sellHoldBuyHoldBuyHold
Price TargetConsensus 12-month target$11.00$110.00$7.58$725.50$97.50
# AnalystsCovering analysts1216422918
Dividend YieldAnnual dividend ÷ price+1.8%+1.6%
Dividend StreakConsecutive years of raises22
Dividend / ShareAnnual DPS$1.19$1.51
Buyback YieldShare repurchases ÷ mkt cap0.0%+12.8%0.0%+1.6%+10.5%
MMS leads this category, winning 1 of 1 comparable metric.
Key Takeaway

AVAH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TDOC leads in 1 (Valuation Metrics).

Best OverallAveanna Healthcare Holdings… (AVAH)Leads 3 of 6 categories
Loading custom metrics...

AVAH vs MMS vs TDOC vs CACI vs SAIC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is AVAH or MMS or TDOC or CACI or SAIC a better buy right now?

For growth investors, Aveanna Healthcare Holdings Inc.

(AVAH) is the stronger pick with 20. 2% revenue growth year-over-year, versus -2. 9% for Science Applications International Corporation (SAIC). Aveanna Healthcare Holdings Inc. (AVAH) offers the better valuation at 6. 4x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Maximus, Inc. (MMS) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — AVAH or MMS or TDOC or CACI or SAIC?

On trailing P/E, Aveanna Healthcare Holdings Inc.

(AVAH) is the cheapest at 6. 4x versus CACI International Inc at 21. 5x. On forward P/E, Maximus, Inc. is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Science Applications International Corporation wins at 0. 56x versus CACI International Inc's 1. 41x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — AVAH or MMS or TDOC or CACI or SAIC?

Over the past 5 years, CACI International Inc (CACI) delivered a total return of +82.

3%, compared to -94. 9% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: CACI returned +406. 9% versus AVAH's -43. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — AVAH or MMS or TDOC or CACI or SAIC?

By beta (market sensitivity over 5 years), Science Applications International Corporation (SAIC) is the lower-risk stock at 0.

27β versus Teladoc Health, Inc. 's 1. 89β — meaning TDOC is approximately 596% more volatile than SAIC relative to the S&P 500. On balance sheet safety, Science Applications International Corporation (SAIC) carries a lower debt/equity ratio of 14% versus 7% for Aveanna Healthcare Holdings Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — AVAH or MMS or TDOC or CACI or SAIC?

By revenue growth (latest reported year), Aveanna Healthcare Holdings Inc.

(AVAH) is pulling ahead at 20. 2% versus -2. 9% for Science Applications International Corporation (SAIC). On earnings-per-share growth, the picture is similar: Aveanna Healthcare Holdings Inc. grew EPS 1952% year-over-year, compared to 7. 4% for Science Applications International Corporation. Over a 3-year CAGR, CACI leads at 11. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — AVAH or MMS or TDOC or CACI or SAIC?

Aveanna Healthcare Holdings Inc.

(AVAH) is the more profitable company, earning 9. 2% net margin versus -7. 9% for Teladoc Health, Inc. — meaning it keeps 9. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVAH leads at 10. 9% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is AVAH or MMS or TDOC or CACI or SAIC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Science Applications International Corporation (SAIC) is the more undervalued stock at a PEG of 0. 56x versus CACI International Inc's 1. 41x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Maximus, Inc. (MMS) trades at 7. 7x forward P/E versus 17. 1x for CACI International Inc — 9. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMS: 71. 2% to $110. 00.

08

Which pays a better dividend — AVAH or MMS or TDOC or CACI or SAIC?

In this comparison, MMS (1.

8% yield), SAIC (1. 6% yield) pay a dividend. AVAH, TDOC, CACI do not pay a meaningful dividend and should not be held primarily for income.

09

Is AVAH or MMS or TDOC or CACI or SAIC better for a retirement portfolio?

For long-horizon retirement investors, Science Applications International Corporation (SAIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

27), 1. 6% yield, +104. 0% 10Y return). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SAIC: +104. 0%, TDOC: -38. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between AVAH and MMS and TDOC and CACI and SAIC?

These companies operate in different sectors (AVAH (Healthcare) and MMS (Industrials) and TDOC (Healthcare) and CACI (Technology) and SAIC (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AVAH is a small-cap high-growth stock; MMS is a small-cap deep-value stock; TDOC is a small-cap quality compounder stock; CACI is a mid-cap quality compounder stock; SAIC is a small-cap deep-value stock. MMS, SAIC pay a dividend while AVAH, TDOC, CACI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

AVAH

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 13%
  • Net Margin > 5%
Run This Screen
Stocks Like

MMS

Income & Dividend Stock

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.7%
Run This Screen
Stocks Like

TDOC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 39%
Run This Screen
Stocks Like

CACI

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

SAIC

Income & Dividend Stock

  • Sector: Technology
  • Market Cap > $100B
  • Dividend Yield > 0.6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform AVAH and MMS and TDOC and CACI and SAIC on the metrics below

Revenue Growth>
%
(AVAH: 27.4% · MMS: -4.1%)
Net Margin>
%
(AVAH: 9.2% · MMS: 7.0%)
P/E Ratio<
x
(AVAH: 6.4x · MMS: 11.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.